176 related articles for article (PubMed ID: 30053340)
21. Shielding of the A1 domain by the D'D3 domains of von Willebrand factor modulates its interaction with platelet glycoprotein Ib-IX-V.
Ulrichts H; Udvardy M; Lenting PJ; Pareyn I; Vandeputte N; Vanhoorelbeke K; Deckmyn H
J Biol Chem; 2006 Feb; 281(8):4699-707. PubMed ID: 16373331
[TBL] [Abstract][Full Text] [Related]
22. Glycosylation sterically inhibits platelet adhesion to von Willebrand factor without altering intrinsic conformational dynamics.
Tischer A; Machha VR; Moon-Tasson L; Benson LM; Auton M
J Thromb Haemost; 2020 Jan; 18(1):79-90. PubMed ID: 31479573
[TBL] [Abstract][Full Text] [Related]
23. Mocarhagin, a novel cobra venom metalloproteinase, cleaves the platelet von Willebrand factor receptor glycoprotein Ibalpha. Identification of the sulfated tyrosine/anionic sequence Tyr-276-Glu-282 of glycoprotein Ibalpha as a binding site for von Willebrand factor and alpha-thrombin.
Ward CM; Andrews RK; Smith AI; Berndt MC
Biochemistry; 1996 Apr; 35(15):4929-38. PubMed ID: 8664285
[TBL] [Abstract][Full Text] [Related]
24. Conformational activation and inhibition of von Willebrand factor by targeting its autoinhibitory module.
Arce NA; Markham-Lee Z; Liang Q; Najmudin S; Legan ER; Dean G; Su AJ; Wilson MS; Sidonio RF; Lollar P; Emsley J; Li R
Blood; 2024 May; 143(19):1992-2004. PubMed ID: 38290109
[TBL] [Abstract][Full Text] [Related]
25. The physical spacing between the von Willebrand factor D'D3 and A1 domains regulates platelet adhesion in vitro and in vivo.
Zhang C; Kelkar A; Nasirikenari M; Lau JTY; Sveinsson M; Sharma UC; Pokharel S; Neelamegham S
J Thromb Haemost; 2018 Mar; 16(3):571-582. PubMed ID: 29251812
[TBL] [Abstract][Full Text] [Related]
26. Binding of the von Willebrand factor A1 domain to histone.
Ward CM; Tetaz TJ; Andrews RK; Berndt MC
Thromb Res; 1997 Jun; 86(6):469-77. PubMed ID: 9219327
[TBL] [Abstract][Full Text] [Related]
27. Epitope mapping of inhibitory antibodies against platelet glycoprotein Ibalpha reveals interaction between the leucine-rich repeat N-terminal and C-terminal flanking domains of glycoprotein Ibalpha.
Cauwenberghs N; Vanhoorelbeke K; Vauterin S; Westra DF; Romo G; Huizinga EG; Lopez JA; Berndt MC; Harsfalvi J; Deckmyn H
Blood; 2001 Aug; 98(3):652-60. PubMed ID: 11468163
[TBL] [Abstract][Full Text] [Related]
28. A mechanism for localized dynamics-driven affinity regulation of the binding of von Willebrand factor to platelet glycoprotein Ibα.
Liu G; Fang Y; Wu J
J Biol Chem; 2013 Sep; 288(37):26658-67. PubMed ID: 23902764
[TBL] [Abstract][Full Text] [Related]
29. Platelet glycoprotein Ibalpha forms catch bonds with human WT vWF but not with type 2B von Willebrand disease vWF.
Yago T; Lou J; Wu T; Yang J; Miner JJ; Coburn L; López JA; Cruz MA; Dong JF; McIntire LV; McEver RP; Zhu C
J Clin Invest; 2008 Sep; 118(9):3195-207. PubMed ID: 18725999
[TBL] [Abstract][Full Text] [Related]
30. Oxidation shuts down an auto-inhibitory mechanism of von Willebrand factor.
Tsai R; Interlandi G
Proteins; 2021 Jun; 89(6):731-741. PubMed ID: 33550613
[TBL] [Abstract][Full Text] [Related]
31. Distinct structural attributes regulating von Willebrand factor A1 domain interaction with platelet glycoprotein Ibalpha under flow.
Miyata S; Ruggeri ZM
J Biol Chem; 1999 Mar; 274(10):6586-93. PubMed ID: 10037753
[TBL] [Abstract][Full Text] [Related]
32. Identification of peptide antagonists to glycoprotein Ibalpha that selectively inhibit von Willebrand factor dependent platelet aggregation.
Benard SA; Smith TM; Cunningham K; Jacob J; DeSilva T; Lin L; Shaw GD; Kriz R; Kelleher KS
Biochemistry; 2008 Apr; 47(16):4674-82. PubMed ID: 18363340
[TBL] [Abstract][Full Text] [Related]
33. von Willebrand factor self-association on platelet GpIbalpha under hydrodynamic shear: effect on shear-induced platelet activation.
Dayananda KM; Singh I; Mondal N; Neelamegham S
Blood; 2010 Nov; 116(19):3990-8. PubMed ID: 20696943
[TBL] [Abstract][Full Text] [Related]
34. Modulation by heparin of the interaction of the A1 domain of Von Willebrand factor with glycoprotein Ib.
Perrault C; Ajzenberg N; Legendre P; Rastegar-Lari G; Meyer D; Lopez JA; Baruch D
Blood; 1999 Dec; 94(12):4186-94. PubMed ID: 10590063
[TBL] [Abstract][Full Text] [Related]
35. The interaction of the von Willebrand factor-A1 domain with platelet glycoprotein Ib/IX. The role of glycosylation and disulfide bonding in a monomeric recombinant A1 domain protein.
Cruz MA; Handin RI; Wise RJ
J Biol Chem; 1993 Oct; 268(28):21238-45. PubMed ID: 8407961
[TBL] [Abstract][Full Text] [Related]
36. Changes in thermodynamic stability of von Willebrand factor differentially affect the force-dependent binding to platelet GPIbalpha.
Auton M; Sedlák E; Marek J; Wu T; Zhu C; Cruz MA
Biophys J; 2009 Jul; 97(2):618-27. PubMed ID: 19619477
[TBL] [Abstract][Full Text] [Related]
37. Type 2B von Willebrand disease mutations differentially perturb autoinhibition of the A1 domain.
Legan ER; Liu Y; Arce NA; Parker ET; Lollar P; Zhang XF; Li R
Blood; 2023 Mar; 141(10):1221-1232. PubMed ID: 36580664
[TBL] [Abstract][Full Text] [Related]
38. Humanized GPIbα-von Willebrand factor interaction in the mouse.
Kanaji S; Orje JN; Kanaji T; Kamikubo Y; Morodomi Y; Chen Y; Zarpellon A; Eberhardt J; Forli S; Fahs SA; Sood R; Haberichter SL; Montgomery RR; Ruggeri ZM
Blood Adv; 2018 Oct; 2(19):2522-2532. PubMed ID: 30287479
[TBL] [Abstract][Full Text] [Related]
39. Dynamic force spectroscopy of glycoprotein Ib-IX and von Willebrand factor.
Arya M; Kolomeisky AB; Romo GM; Cruz MA; López JA; Anvari B
Biophys J; 2005 Jun; 88(6):4391-401. PubMed ID: 15764659
[TBL] [Abstract][Full Text] [Related]
40. Impact of O-linked glycosylation of the VWF-A1-domain flanking regions on platelet interaction.
Schulte am Esch J; Robson SC; Knoefel WT; Eisenberger CF; Peiper M; Rogiers X
Br J Haematol; 2005 Jan; 128(1):82-90. PubMed ID: 15606553
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]